1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EOCENE LTD.
Eocene Ltd.
XNAS: EOCN
2.92-0.09(-2.99%)
252
XNAS Volume

XNAS 15 Oct, 2026 10:45 AM (EDT)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for Eocene is on 16 Oct 2026 for the purpose of Eocene Ltd Second Quarter Earnings Results for 2026See details

Eocene quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Eocene quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEUTRAL

    Quarterly Revenue Eocene Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Quarterly Net Profit Eocene Jun-2026 Quarterly Net Profit is $-3 Million which is growth of -9.1% YoY.

Eocene Ltd., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
2.8232.12.11.31.621.21.42.21.51.9
Operating Profit
-2.8-2-3-2.1-2.1-1.3-1.6-2-1.2-1.4-2.2-1.5-1.9
0.10.10.30.20.10.2-0.50.10.10.1-0.1-00.3
Profit Before Tax
-2.7-1.9-4.8-1.9-2.5-1.1-3.2-1.9-1.1-1.3-2-1.5-1.6
Tax
-------------
⌄
-2.7-1.9-4.8-1.9-2.5-1.1-3.2-1.9-1.1-1.3-2-1.5-1.6
Diluted NI Avail to Com Stockholders Ann.
-2.7-1.9-4.8-1.9-2.5-1.1-3.2-1.9-1.1-1.3-2-1.5-1.6
Basic EPS
-2.9-2.3-7.4-2.6-5-5-15.8-18.5-17.3-22.1-94.1-23-91.2
Diluted EPS After ExtraOrdinary
-2.9-2.3-4.6-2.6-4-5-15.4-18.5-17.3-22.1-94.1-23-91.2
Number Of Shares End
10.80.80.70.50.20.20.10.10.10.10.10
Net Income Continuing Discontinued Operations
-2.7-1.9-4.8-1.9-2.5-1.1-3.2-1.9-1.1-1.3-2-1.5-1.6
Normalized Income
-2.5-1.6-2.6-1.8-1.9-1-1.9-1.8-1-1.1-1.9-1.2-1.5
Interest Income
0.2-0.40.20.1---0.1----
Interest
-------------
Net Interest Income
0.10.10.30.20.10.2-0.50.10.10.1-0.1-00.3
EBIT
-2.9-2-5.2-2.1-2.6-1.3-3.4-2-1.2-1.4-2-1.5-1.9
EBITDA
-2.9-2-5.2-2.1-2.6-1.3-3.4-2-1.2-1.4-1.9-1.5-1.9
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
--0.10000
Profit From Continuing Operations
-2.7-1.9-4.8-1.9-2.5-1.1-3.2-1.9-1.1-1.3-2-1.5-1.6
Normalized EBITDA
-2.8-2-1-2.1-1.6-1.3-1.6-2-1.2-1.4-2.2-1.5-1.9
*All financials are in USD Million and price data in USD

Eocene competitor comparison and performance snapshot within industry

Eocene annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • NEUTRAL

    Annual Revenue Eocene Annual Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Annual Net Profit Eocene Annual Net Profit is $-10 Million which is growth of -37.1% YoY.

Eocene Ltd., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
 21.10.5
Cost Of Rev. Ann.
-
-
 -----------
Gross Profit Ann.
-
-
 -----------
Operating Exp. Ann.
-21.7%
-22.4%
108.56.37.517.732.930.222.412.813.517.410.9
Operating Profit Ann.
-
-
-10-8.5-6.3-7.5-17.7-32.9-30.2-22.4-10.7-12.4-16.9-10.9
38.7%
-7.8%
0.70.8-0.10.40.30.51.21.90.90.100.3
Other Exp. Ann.
-
-
 -2.6-1.10.2-0.5-0.10.30---
PBT Ann.
-
-
-11.3-10.3-7.5-6.9-17.9-32.5-28.8-20.5-9.8-12.3-16.9-10.6
Tax Ann.
-
-
 -----0.10.1
⌄
-
-
-11.3-10.3-7.5-6.9-17.9-32.5-28.8-20.5-9.9-12.3-17-10.6
Diluted NI Avail to Com Stockholders Ann.
-
-
-11.3-10.3-7.5-6.9-17.9-32.5-28.8-20.5-9.9-12.3-17-10.6
EPS Ann.
-
-
 -19.1-64.6-240-1,022.4-1,900.8-1,944-1,396.8-777.6-1,411.2-2,145.6-1,382.4
Diluted EPS Ann.
-
-
 -19.1-64.6-240-1,022.4-1,900.8-1,944-1,396.8-777.6-1,411.2-2,145.6-1,382.4
Number Of Shares End
-
-
 0.80.20.100000000
Total Exp. Ann.
-21.7%
-22.4%
 8.56.37.517.732.930.222.412.813.517.410.9
Net Income Continuing Discontinued Operations Ann.
-
-
-11.3-10.3-7.5-6.9-17.9-32.5-28.8-20.5-9.9-12.3-17-10.6
Normalized Income Ann.
-
-
-8.5-7.2-5.8-6.3-16-30.5-27.2-18.3-8.5-10.9-15.6-9.6
Interest Income Ann.
44.2%
-5.6%
 0.90.50.40.30.61.221---
Interest Ann.
-
-
 -----------
EBITDA Ann.
-
-
-12.2-11.2-7.9-7.3-18.1-33-29.9-22.4-10.4-12.1-16.7-10.8
Reconciled Cost Of Rev. Ann.
-
-
 -----------
Reconciled Depr. Ann.
-
-
 0.1000000.40.20.20.1
Profit From Continuing Operations Ann.
-
-
-11.3-10.3-7.5-6.9-17.9-32.5-28.8-20.5-9.9-12.3-17-10.6
Normalized EBITDA Ann.
-
-
-7.9-5.9-5.1-7.7-17.1-32.7-30.5-22.3-10.4-12.1-16.7-10.8
*All financials are in USD Million and price data in USD
Operating Exp. Ann.
1Y CHG
34.9%
2Y CAGR
6.5%
3Y CAGR
-21.7%
5Y CAGR
-22.4%
7Y CAGR
-5.7%
10Y CAGR
-2.5%
Operating Expenses Annual Cr growth is higher than historical averages.

Eocene balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund Eocene Dec-2025 Total Shareholders Fund is $16 Million which is growth of -3.3% YoY.

  • POSITIVE

    Total Assets Eocene Dec-2025 Total Assets is $19 Million which is growth of 0.7% YoY.

Eocene Ltd., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
3.9%
-18.7%
18.618.516.616.636.652.477.190.619.616.524.3
⌄
-2.2%
-18.8%
2.92.22.83.16.18.27.32.73.95.42.7
⌄
5.6%
-18.6%
15.816.313.913.430.544.269.987.915.811.121.5
Total Capitalization Ann.
5.6%
-18.6%
15.816.313.913.430.544.269.987.915.811.121.6
Tangible Assets Ann.
5.6%
-18.6%
15.816.313.913.430.544.269.987.915.811.121.5
Working Capital Ann.
10.8%
-18.4%
15.81410.511.630.243.869.587.715.311.220.8
Invested Capital Ann.
5.6%
-18.6%
15.816.313.913.430.544.269.987.915.811.121.6
Tangible Book Value Ann.
5.6%
-18.6%
15.816.313.913.430.544.269.987.915.811.121.6
Borrowings Ann.
-
-
-000.20.20.4----
Net Debt Ann.
-
-
-----------
Share Issued Ann.
-
-
0.80.20.100000000
Number Of Shares End
-
-
0.80.20.100000000
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
0.5%
2Y CAGR
5.9%
3Y CAGR
3.9%
5Y CAGR
-18.7%
7Y CAGR
-20.2%
10Y CAGR
-2.6%
Total Assets Annual growth is stable compared to historical averages.
Total Current Liabilities Ann.
1Y CHG
27.3%
3Y CAGR
-3.3%
5Y CAGR
-18.9%
7Y CAGR
0.5%
10Y CAGR
1.1%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-3.1%
2Y CAGR
6.6%
3Y CAGR
5.6%
5Y CAGR
-18.6%
7Y CAGR
-21.7%
10Y CAGR
-3%
Total ShareHolders Funds Annual is falling faster than historical averages.

Eocene ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share Eocene Book Value Per Share is $23 which is growth of -73.8% YoY.

  • NEUTRAL

    ROE Eocene ROE is 0% which is growth of 0% YoY.

Eocene Ltd., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--42.80%-41.65%-67.21%-72.97%-44.43%-24.40%-17.88%-68.15%-83.28%-37.15%
ROE Ann. %
-
-
--49.77%-50.63%-81.36%-86.98%-50.47%-25.94%-19.01%-91.54%-103.94%-40.12%
ROIC %
-
-
--18.5-13.7-18-22.3-20.9-11.2-4.2-32.6-36.3-13.8
OPM Ann. %
-
-
--------525.76%-1,139.54%-3,614.99%-
Inventory Turnover Ratio Ann.
-
-
-----------
Asset Turnover Ann. %
-
-
-------00.10-
Working Capital Turnover Ann.
-
-
00.10
Quick Ratio Ann.
-
-
-7.24.74.55.96.410.933.453.49.1
Current Ratio Ann.
-
-
-7.44.84.86.16.51133.453.49.2
Interest Coverage Ratio Ann.
-
-
-----------
LT Debt To Equity Ann.
-
-
---00----
*All financials are in USD Million and price data in USD

Eocene cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Eocene Cash From Operating Activity is $-6 Million which is growth of -7.4% YoY.

  • NEGATIVE

    Net Cash Flow Eocene Net Cash Flow is $-1 Million which is growth of -137.0% YoY.

Eocene Ltd., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
-6.3-5.9-6.1-18.5-32.9-26.3-14.9-9-12.1-12.1-8.5
-
-
-3.4-1.10.817.611.516.56.7-606.46.3-11.1
348.1%
62.3%
98.86.20.117.40.80.180.215.64.7-
Cash Plus Cash Eqv. End Of Year Ann.
25%
-10.4%
4.14.832.137.11624.2133.14.2
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-0.71.80.9-0.9-4.1-9-8.111.19.9-1.1-19.6
Cash Plus Cash Eqv. Begin Of Year Ann.
17%
-21.4%
4.832.137.11624.2133.14.223.7
Income Tax Paid Supplemental Data Ann.
-
-
------0.1-0.1-
Interest Paid Supplemental Data Ann.
-
-
-----1.220.90.20.40.5
Capex Ann.
-
-
----0-0-0-0.1-0-0-0.2
Issuance Of Capital Stock Ann.
348.1%
66.7%
98.86.20.117.40.779.2154.5-
Issuance Of Debt Ann.
-
-
-----------
Repayment Of Debt Ann.
-
-
-----------
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-6.3-5.9-6.1-18.5-32.9-26.3-15-9.1-12.1-12.2-8.6
*All financials are in USD Million and price data in USD
Cash from Financing Act. Ann.
1Y CHG
2.3%
2Y CAGR
20.5%
3Y CAGR
348.1%
5Y CAGR
62.3%
7Y CAGR
-26.8%
Cash from Financing Annual Activity growth is stable compared to historical averages.